Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07048886
PHASE4

Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

Sponsor: Center for Sight Las Vegas

View on ClinicalTrials.gov

Summary

The primary objective of this study is to determine if the addition of Rocklatan post-Hydrus will provide additional intraocular pressure lowering.

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

68

Start Date

2025-07-15

Completion Date

2026-12-31

Last Updated

2025-07-03

Healthy Volunteers

No

Interventions

DRUG

Rocklatan (netarsudil 0.02% and latanoprost 0.005%)

Additional intraocular eye pressure lowering post-Hydrus

DRUG

Systane

Placebo Comparator (artificial tears)

Locations (1)

Center for Sight

Las Vegas, Nevada, United States